|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-3-25
|
|
pubmed:abstractText |
In colorectal cancer (CRC), CD133 expression is an independent prognostic marker associated with adverse clinical outcome. The CD133 epitope AC133 allowed isolating stem cells from normal and cancerous tissues, although its use in colon was questioned. We aimed to identify differences between AC133 and AC133 cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/AC133 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/EGR1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Early Growth Response Protein 1,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/LGR5 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, G-Protein-Coupled,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1465-3931
|
|
pubmed:author |
pubmed-author:AignerMaximilianM,
pubmed-author:BrandKarstenK,
pubmed-author:EngelFelixF,
pubmed-author:ErnstAurélieA,
pubmed-author:KloorMatthiasM,
pubmed-author:KochMoritzM,
pubmed-author:LichterPeterP,
pubmed-author:NakataSusumuS,
pubmed-author:RadlwimmerBernhardB,
pubmed-author:RahbariNuhN,
pubmed-author:SchlotterMagdalenaM,
pubmed-author:SchmittSteffenS,
pubmed-author:SteinertGunnarG,
pubmed-author:WeitzJürgenJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
220-7
|
|
pubmed:meshHeading |
pubmed-meshheading:21436631-Antigens, CD,
pubmed-meshheading:21436631-Cell Line, Tumor,
pubmed-meshheading:21436631-Colorectal Neoplasms,
pubmed-meshheading:21436631-Early Growth Response Protein 1,
pubmed-meshheading:21436631-Epitopes,
pubmed-meshheading:21436631-Flow Cytometry,
pubmed-meshheading:21436631-Gene Expression Profiling,
pubmed-meshheading:21436631-Glycoproteins,
pubmed-meshheading:21436631-Humans,
pubmed-meshheading:21436631-Liver Neoplasms,
pubmed-meshheading:21436631-Microsatellite Instability,
pubmed-meshheading:21436631-Peptides,
pubmed-meshheading:21436631-RNA, Messenger,
pubmed-meshheading:21436631-RNA, Neoplasm,
pubmed-meshheading:21436631-Receptors, G-Protein-Coupled,
pubmed-meshheading:21436631-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:21436631-Signal Transduction,
pubmed-meshheading:21436631-Tumor Markers, Biological
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors.
|
|
pubmed:affiliation |
Division of Molecular Genetics, German Cancer Research Center, University of Heidelberg, Heidelberg, Germany. aurelie.ernst@ki.se
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
